Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  6/27/2016
Cedars Sinai Medical Center Cedars Sinai 4
mi
from
Los Angeles, CA
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 6/27/2016
Cedars Sinai Medical Center Cedars Sinai 4
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  6/27/2016
H. Lee Moffitt Cancer Center & Research Institute SC-1
mi
from
Tampa, FL
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 6/27/2016
H. Lee Moffitt Cancer Center & Research Institute SC-1
mi
from
Tampa, FL
Click here to add this to my saved trials
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  6/27/2016
Dana Farber Cancer Institute SC-6
mi
from
Boston, MA
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 6/27/2016
Dana Farber Cancer Institute SC-6
mi
from
Boston, MA
Click here to add this to my saved trials
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated:  6/27/2016
University of Texas/MD Anderson Cancer Center UT MD Anderson Cancer Ctr
mi
from
Houston, TX
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
A Phase I, Multi-center, Open-label, Dose Escalation Study of Pasireotide (SOM230) LAR in Patients With Advanced Neuroendocrine Tumors (NETs)
Status: Enrolling
Updated: 6/27/2016
University of Texas/MD Anderson Cancer Center UT MD Anderson Cancer Ctr
mi
from
Houston, TX
Click here to add this to my saved trials
Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Status: Enrolling
Updated:  7/6/2016
Massachusetts General Hospital
mi
from
Boston, MA
Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Status: Enrolling
Updated: 7/6/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Status: Enrolling
Updated:  7/6/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Status: Enrolling
Updated: 7/6/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Birmingham, AL
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Pheonix, AZ
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Pheonix, AZ
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
New Haven, CT
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Gainesville, FL
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Chicago, IL
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Evanston, IL
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Kansas City, KA
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Boston, MA
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Detroit, MI
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Amherst, NY
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Amherst, NY
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
New York, NY
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Cleveland, OH
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Columbus, OH
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Houston, TX
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Seattle, WA
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
Clinical Research Facility
mi
from
Morgantown, WV
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated:  7/6/2016
mi
from
Camperdown,
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib With Lomustine to the Efficacy of Lomustine Alone
Status: Enrolling
Updated: 7/6/2016
mi
from
Camperdown,
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
PHASE II STUDY OF PREIRRADIATION PCV CHEMOTHERAPY IN PATIENTS WITH SUPRATENTORIAL LOW-GRADE GLIOMAS
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated:  7/13/2016
University of California at San Francisco
mi
from
San Francisco, CA
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated: 7/13/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated:  7/13/2016
Stanford University
mi
from
Stanford, CA
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated: 7/13/2016
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated:  7/13/2016
Moffitt Cancer Center and Research Institute
mi
from
Tampa, FL
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
A Phase II Study of Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Status: Enrolling
Updated: 7/13/2016
Moffitt Cancer Center and Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Phase I Study of Anti-IGF-1R Monoclonal Antibody, IMC-A12, and mTOR Inhibitor, Everolimus, in Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Status: Enrolling
Updated:  7/14/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Phase I Study of Anti-IGF-1R Monoclonal Antibody, IMC-A12, and mTOR Inhibitor, Everolimus, in Advanced Low to Intermediate Grade Neuroendocrine Carcinoma
Status: Enrolling
Updated: 7/14/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
Assessment of Early Treatment Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
Status: Enrolling
Updated:  7/18/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
Assessment of Early Treatment Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
Status: Enrolling
Updated: 7/18/2016
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials